P3 Health Partners Inc. (PIII) has a negative trailing P/E of -0.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -1,721.02%.
Criteria proven by this page:
Overall SharesGrow Score: 35/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2018 | -5.3 | 0.00 | 0.00 | 2.63 | - |
| 2019 | -5.5 | 0.11 | -5.48 | 1.58 | - |
| 2020 | -12.2 | 1.23 | -2.94 | 0.78 | - |
| 2021 | -1.9 | -0.01 | 1.07 | 0.46 | - |
| 2022 | -0.3 | 0.00 | 13.07 | 0.07 | - |
| 2023 | -2.2 | 0.02 | 0.87 | 0.10 | - |
| 2024 | -0.2 | 0.00 | 0.43 | 0.02 | - |
| 2025 | -0.1 | 0.02 | -0.07 | 0.01 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2018 | $-92.04 | $87.7M | $-43.8M | -49.9% |
| 2019 | $-44.10 | $145.48M | $-41.97M | -28.8% |
| 2020 | $-39.73 | $485.54M | $-31.41M | -6.5% |
| 2021 | $-188.17 | $491.06B | $-10.08M | -0% |
| 2022 | $-324.84 | $1.05B | $-270.13M | -25.7% |
| 2023 | $-30.44 | $1.27B | $-57.77M | -4.6% |
| 2024 | $-54.06 | $1.5B | $-135.85M | -9.1% |
| 2025 | $-45.26 | $1.46B | $-147.95M | -10.1% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-11.60 | $-11.62 – $-11.58 | $1.58B | $1.58B – $1.59B | 1 |
| 2027 | $-3.16 | $-3.16 – $-3.16 | $1.55B | $1.55B – $1.55B | 1 |
